Brown Advisory’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Brown Advisory's RPRX Position: Q2 2026 in Review
Brown Advisory increased its Royalty Pharma (RPRX) stake by 5.1% in Q2 2026, buying an estimated $25.1K and bringing the position to 9,903 shares worth $555K. The position accounts for ﹤0.01% of the portfolio, ranked #1106.
Brown Advisory first reported a position in RPRX in Q2 2020 and has held it in 4 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Brown Advisory held 9,903 shares of Royalty Pharma worth $555K as of Q2 2026.
- Brown Advisory bought 482 Royalty Pharma shares in Q2 2026, an estimated $25.1K.
- Royalty Pharma made up ﹤0.01% of Brown Advisory's portfolio in Q2 2026, its #1106 holding.
- Brown Advisory first reported a position in Royalty Pharma in Q2 2020 and has held it in 4 quarters since.
- 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.